#USA #Boston #Women's Health #Cindy Eckert #Sprout Pharmaceuticals

Cindy Eckert to Headline the 2025 Women’s Health Summit at Harvard Business School

Harvard Business School has announced that Cindy Eckert, the pioneering Founder and CEO of Sprout Pharmaceuticals, will be the Keynote Speaker for the upcoming 2025 Women's Health Summit. Scheduled for November 8, 2025, this much-anticipated event will take place at the David Rubenstein Treehouse at Harvard Business School in Boston. The summit is organized by the Harvard Business School Healthcare Club’s Women’s Health Special Interest Group, which aims to bring together key players—investors, innovators, and industry leaders—to navigate the evolving landscape of women's health.

Eckert will launch the proceedings with her keynote address, drawing from her extensive experience in advocating for women’s health. She has spent over a decade championing equity, access, and innovation, challenging the norms within the healthcare industry. Her remarks will highlight how women's health, often neglected, is taking center stage in today’s critical business discussions. As Eckert puts it herself:

“Harvard shaping a stage for women's health innovation is powerful — it signals that what was once sidelined is now a top-tier business conversation.”

Cindy Eckert has made significant strides in the field of women’s health, notably with the creation of Sprout Pharmaceuticals. Under her leadership, the company developed Addyi (flibanserin), the first-ever FDA-approved treatment for Hypoactive Sexual Desire Disorder (HSDD) in women. This breakthrough not only transformed treatment paradigms but also sparked broader conversations around women’s sexual health and wellness. Eckert's initiative not only marked a milestone in medicine but also brought societal awareness to long-standing issues in women's health.

A Platform for Change

The 2025 Women's Health Summit is supported by a coalition of sponsors, including notable names like J.P. Morgan, Cooley, and the Harvard Business School Health Care Initiative. The lineup of speakers at the summit includes executives from major health-centric ventures such as Maven, Midi, Oura, Evvy, and Wisp. In addition, the summit will feature a student pitch competition, allowing emerging entrepreneurs in women’s health to showcase their ventures.

A Growing Movement

As it enters its second year, the summit has solidified its status as a pivotal gathering for future innovators. It provides an essential platform for discussing solutions to the unique healthcare challenges that women face, addressing the gaps that have historically been overlooked.

With her extensive experience in the sector and commitment to advocacy, Eckert’s keynote promises to inspire and energize attendees, encouraging a collective push towards a future where women's health issues are no longer neglected. Sprout Pharmaceuticals is at the forefront of this transformation, demonstrating that addressing women’s health can spur business growth while fostering equity in healthcare access.

The 2025 Women’s Health Summit is not just an event; it’s a movement. For those interested in shaping the future of women’s health, this is a must-attend occasion.

About Sprout Pharmaceuticals

Sprout Pharmaceuticals is revolutionizing women’s health with its innovative treatments that cater to long-neglected needs, such as sexual wellness and conditions related to perimenopause and menopause. The organization’s commitment to scientific discovery and advocacy reflects its goal of providing comprehensive support for women who have felt underserved in their healthcare journeys.

As Cindy Eckert stated, addressing these issues is crucial for fostering a healthier, more equitable future. With her leadership, Sprout continues to challenge traditional norms and drive impactful change in the healthcare landscape.

For more information on the summit and to register, visit the Harvard Business School Healthcare Club website.